<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04958668</url>
  </required_header>
  <id_info>
    <org_study_id>20-1050</org_study_id>
    <nct_id>NCT04958668</nct_id>
  </id_info>
  <brief_title>Prospective Evaluation of Volatile Sedation After Heart Valve Surgery</brief_title>
  <official_title>Prospective Evaluation of Volatile Sedation With Regard to Awakening Behaviour and Extubation Capacity in Patients Undergoing Heart Valve Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Goethe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Goethe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery is a complex operative procedure with a substantial risk of postoperative&#xD;
      complications, so that patients undergoing valve surgery are usually transferred to the&#xD;
      intensive care unit postoperatively. Various substances are used to maintain the required&#xD;
      sedation, such as volatile anaesthetics and intravenous sedatives combined with analgetic&#xD;
      therapy using opioids.&#xD;
&#xD;
      The study intends to investigate to what extent the already well-described effect of volatile&#xD;
      anaesthetics on recovery can be realised despite the need for differentiated intensive care&#xD;
      and medical management.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to extubation</measure>
    <time_frame>through study completion, an average of 2 days</time_frame>
    <description>Time from admission on ICU until awakening and Extubation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to neurocognitive assessability</measure>
    <time_frame>through study completion, an average of 2 days</time_frame>
    <description>Time from admission on ICU until awake and neurocognitive assessable.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Valve Heart Disease</condition>
  <condition>Awakening Early</condition>
  <arm_group>
    <arm_group_label>Volatile procedere</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intensive care treatment with demand-adapted sedation with volatile anaesthetics</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional procedere</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Conventional Intensive care treatment with demand-adapted sedation with intravenous sedatives</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Post-operative intensive care using volatile sedation</intervention_name>
    <description>Patients admitted after valve surgery are receiving intensive care using volatile sedative per anaesthetic conserving device. The subject of the study is medical and nursing time management..</description>
    <arm_group_label>Volatile procedere</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Valve reconstruction or valve replacement&#xD;
&#xD;
          -  Must be capable to giving written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intolerance to volatile anaesthetics (e.g. malignant hyperthermia)&#xD;
&#xD;
          -  Severe obstructive pulmonary disease&#xD;
&#xD;
          -  Extended aortic arch or ascending aorta surgery&#xD;
&#xD;
          -  Age &lt;18 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Armin N Flinspach, M.D.</last_name>
    <phone>+49 69 63 01 5865</phone>
    <email>armin.flinspach@kgu.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elisabeth H Adam, M.D.</last_name>
    <phone>+49 69 63 01 5865</phone>
    <email>elisabeth.adam@kgu.de</email>
  </overall_contact_backup>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 28, 2021</study_first_submitted>
  <study_first_submitted_qc>July 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2021</study_first_posted>
  <last_update_submitted>July 1, 2021</last_update_submitted>
  <last_update_submitted_qc>July 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Goethe University</investigator_affiliation>
    <investigator_full_name>Armin N. Flinspach</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

